Prudential Sector Funds, Inc. · net assets $1.5B · 55 holdings as of August 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 90.1% · STIV: 9.9%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $11M | $12M | $16.3M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $23.8M | $25M | $31.2M |
| Net realized gain (non-derivative) | $9.35M | $24.4M | $1.31M |
| Net unrealized appreciation (non-derivative) | $102M | -$40.2M | $53.9M |
The three months of the reporting period, as filed; month 3 ends August 31, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Eli Lilly & Company EC | $252M | 16.84% |
| Prudential Government Money Market Fund Inc. STIV | $107M | 7.14% |
| Merck & Company Inc EC | $105M | 6.99% |
| Unitedhealth Group Inc EC | $83.4M | 5.57% |
| Thermo Fisher Scientific Inc EC | $72.2M | 4.82% |
| Vertex Pharmaceuticals Inc EC | $62M | 4.14% |
| Argenx Se EC | $52.4M | 3.50% |
| Danaher Corp EC | $49.9M | 3.33% |
| Prudential Investment Portfolios 2 STIV | $45.9M | 3.06% |
| Cvs Health Corp EC | $41.5M | 2.77% |
| Insmed Inc EC | $36.1M | 2.41% |
| Roivant Sciences Ltd EC | $35.4M | 2.36% |
| Beone Medicines Ltd EC | $34.3M | 2.29% |
| Palvella Therapeutics Inc EC | $29.3M | 1.96% |
| Kymera Therapeutics Inc EC | $25.6M | 1.71% |
| Edwards Lifesciences Corp EC | $24.3M | 1.62% |
| Elanco Animal Health Inc EC | $22.2M | 1.48% |
| Vaxcyte Inc EC | $21.8M | 1.46% |
| Agilent Technologies Inc EC | $21.3M | 1.42% |
| Align Technology Inc EC | $21.1M | 1.41% |
| Dianthus Therapeutics Inc EC | $20.1M | 1.34% |
| Revolution Medicines Inc EC | $19.3M | 1.29% |
| Tarsus Pharmaceuticals Inc EC | $18.4M | 1.23% |
| Elevance Health Inc EC | $17.9M | 1.20% |
| Intuitive Surgical Inc EC | $17.8M | 1.19% |
| Scholar Rock Holding Corp EC | $17.5M | 1.17% |
| Erasca Inc EC | $16.7M | 1.12% |
| Protagonist Therapeutics Inc EC | $16.4M | 1.10% |
| Uniqure Nv EC | $16.4M | 1.10% |
| Disc Medicine Inc EC | $15.6M | 1.04% |
| Cabaletta Bio Inc EC | $15.4M | 1.03% |
| Tandem Diabetes Care Inc EC | $15M | 1.00% |
| Newamsterdam Pharma Company Nv EC | $13.5M | 0.90% |
| Lonza Group Ag EC | $13.4M | 0.90% |
| Apnimed Inc EC | $12.8M | 0.86% |
| Veradermics Inc EC | $12.6M | 0.84% |
| Immunovant Inc EC | $11.3M | 0.76% |
| Celcuity Inc EC | $11.1M | 0.74% |
| Avalyn Pharma Inc EC | $11.1M | 0.74% |
| Lb Pharmaceuticals Inc EC | $10.9M | 0.73% |
| Seaport Therapeutics Inc EC | $10.4M | 0.69% |
| Arcutis Biotherapeutics Inc EC | $9.38M | 0.63% |
| Abivax Sa EC | $9.34M | 0.62% |
| Kardigan Inc EC | $8.26M | 0.55% |
| Xenon Pharmaceuticals Inc EC | $7.87M | 0.53% |
| Mineralys Therapeutics Inc EC | $7.41M | 0.49% |
| Spyre Therapeutics Inc EC | $7.34M | 0.49% |
| Oruka Therapeutics Inc EC | $7.08M | 0.47% |
| Sionna Therapeutics Inc EC | $5.63M | 0.38% |
| Enliven Therapeutics Inc EC | $5.58M | 0.37% |
| Crescent Biopharma Inc EC | $5.17M | 0.35% |
| Neurogene Inc EC | $4.57M | 0.31% |
| Damora Therapeutics Inc EC | $4.31M | 0.29% |
| Tyra Biosciences Inc EC | $3.79M | 0.25% |
| Cabaletta Bio Inc Warrant EC | $1.3M | 0.09% |
Loading...